AICAR stimulates IL-6 production via p38 MAPK in cardiac fibroblasts in adult mice: A possible role for AMPK

Biochemical and Biophysical Research Communications

Volumn 337, Issue 4, 2005, Pages 1139-1144

  Du, Jian Hai ^a   Xu, Ning ^a   Song, Yao ^a   Xu, Ming ^a   Lu, Zhi Zhen ^a   Han, Chide ^a   Zhang, You Yi ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

AMPK; Cardiac fibroblasts; IL 6; p38 MAPK

Indexed keywords

5 AMINOIMIDAZOLE 4 CARBOXAMIDE 1 4 RIBOFURANOSIDE; ADENYLATE KINASE; FURAN DERIVATIVE; INTERLEUKIN 6; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; UNCLASSIFIED DRUG;

ADULTHOOD; ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FIBROBLAST; HEART MUSCLE CELL; IMMUNOFLUORESCENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TIME; WESTERN BLOTTING;

AGING; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; FIBROBLASTS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; MULTIENZYME COMPLEXES; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RIBONUCLEOTIDES;

ANIMALIA;

EID: 27144511497     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.09.174     Document Type: Article

References (50)

1. B.E. Kemp, K.I. Mitchelhill, D. Stapleton, B.J. Michell, Z.P. Chen, and L.A. Witters Dealing with energy demand: the AMP-activated protein kinase Trends Biochem. Sci. 24 1999 22 25
2. D. Carling AMP-activated protein kinase: balancing the scales Biochimie 87 2005 87 91
3. N. Kudo, J.G. Gillespie, L. Kung, L.A. Witters, R. Schulz, A.S. Clanachan, and G.D. Lopaschuk Characterization of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia Biochim. Biophys. Acta 1301 1996 67 75
4. S.J. Baron, J. Li, R.R. Russell, D. Neumann, E.J. Miller, R. Tuerk, T. Wallimann, R.L. Hurley, L.A. Witters, and L.H. Young Dual mechanisms regulating AMPK kinase action in the ischemic heart Circ. Res. 96 2005 337 345
5. M.H. Zou, X.Y. Hou, C.M. Shi, S. Kirkpatick, F. Liu, M.H. Goldman, and R.A. Cohen Activation of 5′-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia- reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite J. Biol. Chem. 278 2003 34003 34010
6. S.L. Choi, S.J. Kim, K.T. Lee, J. Kim, J. Mu, M.J. Birnbaum, S. Soo Kim, and J. Ha The regulation of AMP activated protein kinase by H(2)O(2) Biochem. Biophys. Res. Commun. 287 2001 92 97
7. D. An, G. Kewalramani, D. Qi, T. Pulinilkunnil, S. Ghosh, A. Abrahani, R. Wambolt, M. Allard, S.M. Innis, and B. Rodrigues beta-Agonist stimulation produces changes in cardiac AMPK and coronary lumen LPL only during increased workload Am. J. Physiol. Endocrinol. Metab. 288 2005 1120 1127
8. Z.P. Chen, K.I. Mitchelhill, B.J. Michell, D. Stapleton, I. Rodriguez-Crespo, L.A. Witters, D.A. Power, P.R. Ortiz de Montellano, and B.E. Kemp AMP-activated protein kinase phosphorylation of endothelial NO synthase FEBS Lett. 443 1999 285 289
9. H.C. Chen, G. Bandyopadhyay, M.P. Sajan, Y. Kanoh, M. Standaert, R.V. Farese Jr., and R.V. Farese Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-d- riboside (AICAR)-stimulated glucose transport J. Biol. Chem. 277 2002 23554 23562
10. D. Meisse, M. Van de Casteele, C. Beauloye, I. Hainault, B.A. Kefas, M.H. Rider, F. Foufelle, and L. Hue Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells FEBS Lett. 526 2002 38 42
11. X. Xi, J. Han, and J.Z. Zhang Stimulation of glucose transport by AMP-activated protein kinase via activation of p38 mitogen-activated protein kinase J. Biol. Chem. 276 2001 41029 41034
12. M. Eghbali Cardiac fibroblasts: function, regulation of gene expression, and phenotypic modulation Basic Res. Cardiol. 87 1992 183 189
13. M.O. Gray, C.S. Long, J.E. Kalinyak, H.T. Li, and J.S. Karliner Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts Cardiovasc. Res. 40 1998 352 363
14. Y. Moriguchi, H. Matsubara, Y. Mori, S. Murasawa, H. Masaki, K. Maruyama, Y. Tsutsumi, N. Musi, M.F. Hirshman, J. Nygren, M. Svanfeldt, P. Bavenholm, O. Rooyackers, G. Zhou, J.M. Williamson, O. Ljunqvist, S. Efendic, D.E. Moller, A. Thorell, and L.J. Goodyear Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes Diabetes 51 2002 2074 2081
15. A.J. van Wamel, C. Ruwhof, L.E. van der Valk-Kokshoom, P.I. Schrier, and A. van der Laarse The role of angiotensin II, endothelin-1 and transforming growth factor-beta as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy Mol. Cell Biochem. 218 2001 113 124
16. F. Jaffre, J. Callebert, A. Sarre, N. Etienne, C.G. Nebigil, J.M. Launay, L. Maroteaux, and L. Monassier Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts Circulation 110 2004 969 974
17. C. Freund, R. Schmidt-Ullrich, A. Baurand, S. Dunger, W. Schneider, P. Loser, A. El-Jamali, R. Dietz, C. Scheidereit, and M.W. Bergmann Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol induced cardiac hypertrophy in vivo Circulation 111 2005 2319 2325
18. B. Dawn, Y.T. Xuan, Y. Guo, A. Rezazadeh, A.B. Stein, G. Hunt, W.J. Wu, W. Tan, and R. Bolli IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2 Cardiovasc. Res. 64 2004 61 71
19. K. Matsushita, S. Iwanaga, T. Oda, K. Kimura, M. Shimada, M. Sano, A. Umezawa, J.I. Hata, and S. Ogawa Interleukin-6/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis Lab. Invest. 2005
20. B. Chandrasekar, D.H. Mitchell, J.T. Colston, and G.L. Freeman Regulation of CCAAT/enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia /reperfusion Circulation 99 1999 427 433
21. M. Nian, P. Lee, N. Khaper, and P. Liu Inflammatory cytokines and postmyocardial infarction remodeling Circ. Res. 94 2004 1543 1553
22. A. Burger, M. Benicke, A. Deten, and H.G. Zimmer Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts Am. J. Physiol. Heart Circ. Physiol. 281 2001 H14 H21
23. M. Sano, K. Fukuda, T. Sato, H. Kawaguchi, M. Suematsu, S. Matsuda, S. Koyasu, H. Matsui, K. Yamauchi-Takihara, M. Harada, Y. Saito, and S. Ogawa ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts Circ. Res. 89 2001 661 669
24. E.A. Palmieri, G. Benincasa, F. Di Rella, C. Casaburi, M.G. Monti, G. De Simone, L. Chiariotti, L. Palombini, C.B. Bruni, L. Sacca, and A. Cittadini Differential expression of TNF-alpha, IL-6, and IGF-1 by graded mechanical stress in normal rat myocardium Am. J. Physiol. Heart Circ. Physiol. 282 2000 H926 H934
25. R. Tian, N. Musi, J. D'Agostino, M.F. Hirshman, and L.J. Goodyear Increased adenosine monophosphate- activated protein kinase activity in rat hearts with pressure-overload hypertrophy Circulation 104 2001 1664 1669
26. M. Frederich, L. Zhang, and J.A. Balschi Hypoxia and AMP independently regulate AMP-activated protein kinase activity in heart Am. J. Physiol. Heart Circ. Physiol. 288 2005 H2412 H2421
27. J.E. Sullivan, K.J. Brocklehurst, A.E. Marley, F. Carey, D. Carling, and R.K. Beri Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase FEBS Lett. 353 1994 33 36
28. J.M. Corton, J.G. Gillespie, S.A. Hawley, and D.G. Hardie 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem. 229 1995 558 565
29. F. Yin, P. Li, M. Zheng, L. Chen, Q. Xu, K. Chen, Y.Y. Wang, Y.Y. Zhang, and C. Han Interleukin-6 family of cytokines mediates isoproterenol-induced delayed STAT3 activation in mouse heart J. Biol. Chem. 278 2003 21070 21075
30. D. Carling AMPK Curr. Biol. 14 2004 R220
31. R. Beyaert, A. Cuenda, W. Vanden Berghe, S. Plaisance, J.C. Lee, G. Haegeman, P. Cohen, and W. Fiers The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor EMBO J. 15 1996 1914 1923
32. A. Krause, H. Holtmann, S. Eickemeier, R. Winzen, M. Szamel, K. Resch, J. Saklatvala, and M. Kracht Stress- activated protein kinase/Jun N-terminal kinase is required for interleukin (IL)-1-induced IL-6 and IL-8 gene expression in the human epidermal carcinoma cell line KB J. Biol. Chem. 273 1998 23681 23689
33. D.A. Rees, B.M. Lewis, M.D. Lewis, K. Francis, M.F. Scanlon, and J. Ham Adenosine-induced IL-6 expression in pituitary folliculostellate cells is mediated via A2b adenosine receptors coupled to PKC and p38 MAPK Br. J. Pharmacol. 140 2003 764 772
34. S. Devaraj, S.K. Venugopal, U. Singh, and I. Jialal Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta} Diabetes 54 2005 85 91
35. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M.F. Hirshman, L.J. Goodyear, and D.E. Moller Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 108 2001 1167 1174
36. L.G. Fryer, A. Parbu-Patel, and D. Carling The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways J. Biol. Chem. 277 2002 25226 25232
37. S.A. Hawley, A.E. Gadalla, G.S. Olsen, and D.G. Hardie The antidiabetic drug metformin activates the AMP- activated protein kinase cascade via an adenine nucleotide-independent mechanism Diabetes 51 2002 2420 2425
38. C. MacDonald, J.F. Wojtaszewski, B.K. Pedersen, B. Kiens, and E.A. Richter Interleukin-6 release from human skeletal muscle during exercise: relation to AMPK activity J. Appl. Physiol. 95 2003 2273 2277
39. Y. Nishino, T. Miura, T. Miki, J. Sakamoto, Y. Nakamura, Y. Ikeda, H. Kobayashi, and K. Shimamoto Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection Cardiovasc. Res. 61 2004 610 619
40. J.G. Bode, T. Peters-Regehr, F. Schliess, and D. Haussinger Activation of mitogen-activated protein kinases and IL-6 release in response to lipopolysaccharides in Kupffer cells is modulated by anisoosmolarity J. Hepatol. 28 1998 795 802
41. A. Kondo, M. Mogi, Y. Koshihara, and A. Togari Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells Biochem. Pharmacol. 61 2001 319 326
42. A. Zampetaki, Z. Zhang, Y. Hu, and Q. Xu Biomechanical stress induces IL-6 expression in smooth muscle cells via Ras/Rac1-p38 MAPK-NF-kappaB signaling pathways Am. J. Physiol. Heart Circ. Physiol. 288 2005 H2946 H2954
43. H.C. Chen, G. Bandyopadhyay, M.P. Sajan, Y. Kanoh, M. Standaert, R.V. Farese, and R.V. Farese Jr. Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4- carboxamide-1-beta-d- riboside (AICAR)-stimulated glucose transport J. Biol. Chem. 277 2002 23554 23562
44. Y.S. amaguchi, H. Katahira, S. Ozawa, Y. Nakamichi, T. Tanaka, T. Shimoyama, K. Takahashi, K. Yoshimoto, M. Ohara-Imaizumi, S. Nagamatsu, and H. Ishida Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3L1 adipocytes Am. J. Physiol. Endocrinol. Metab. 289 2005 E643 E649
45. N. Ouchi, R. Shibata, and K. Walsh AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle Circ. Res. 96 2005 838 846
46. J. Walker, H.B. Jijon, H. Diaz, P. Salehi, T. Churchill, and K.L. Madsen 5-aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK Biochem. J. 385 2005 485 491
47. A. Pelletier, E. Joly, M. Prentki, and L. Coderre Adenosine 5′-monophosphate-activated protein kinase and p38 mitogen activated protein kinase participate in the stimulation of glucose uptake by dinitrophenol in adult cardiomyocytes Endocrinology 146 2005 2285 2294
48. K. Lemieux, D. Konrad, A. Klip, and A. Marette The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle FASEB J. 17 2003 1658 1665
49. S. Giri, N. Nath, B. Smith, B. Viollet, A.K. Singh, and I. Singh 5-aminoimidazole- 4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase J. Neurosci. 24 2004 479 487
50. A.S. Lihn, N. Jessen, S.B. Pedersen, S. Lund, and B. Richelsen AICAR stimulates adiponectin and inhibits cytokines in adipose tissue Biochem. Biophys. Res. Commun. 316 2004 853 858